Bio Green Med Solution Inc Preferred Stock (BGMSP)

BGMSP was delisted on the 20th of March, 2026.

• Market cap: $195K
• Sector: Healthcare
• Industry: Biotechnology

About: Bio Green Med Solution Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.

Employees: 12